Le cluster Jacques Barbet - Jean-François Chatal
| 000023 (2012) | Pierre-Yves Salaun (France) ; Loïc Campion ; Claire Bournaud ; Alain Faivre-Chauvet ; Jean-Philippe Vuillez ; David Taieb ; Catherine Ansquer ; Caroline Rousseau ; Françoise Borson-Chazot ; Stéphane Bardet ; Aurore Oudoux ; Bertrand Cariou ; Eric Mirallié ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Françoise Kraeber-Bodéré | Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement. |
| 000094 (2006) | Françoise Kraeber-Bodéré (France) ; Caroline Rousseau ; Caroline Bodet-Milin ; Ludovic Ferrer ; Alain Faivre-Chauvet ; Loïc Campion ; Jean-Philippe Vuillez ; Anne Devillers ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet | Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. |
| 000022 (2012) | Françoise Kraeber-Bodéré (France) ; Pierre-Yves Salaun ; Catherine Ansquer ; Delphine Drui ; Eric Mirallié ; Alain Faivre-Chauvet ; Jacques Barbet ; David M Goldenberg ; Jean-François Chatal | Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC). |
| 000095 (2006) | Jean-François Chatal (France) ; Loïc Campion ; Françoise Kraeber-Bodéré ; Stephane Bardet ; Jean-Philippe Vuillez ; Bernard Charbonnel ; Vincent Rohmer ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jacques Barbet ; | Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group. |
| 000129 (2003) | Françoise Kraeber-Bodéré (France) ; Alain Faivre-Chauvet ; Ludovic Ferrer ; Jean-Philippe Vuillez ; Pierre-Yves Brard ; Caroline Rousseau ; Isabelle Resche ; Anne Devillers ; Sophie Laffont ; Manuel Bardiès ; Ken Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet | Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial. |
| 000139 (2002) | Françoise Kraeber-Bodéré (France) ; Catherine Saï-Maurel ; Loïc Campion ; Alain Faivre-Chauvet ; Eric Mirallié ; Michel Chérel ; Stéphane Supiot ; Jacques Barbet ; Jean-François Chatal ; Philippe Thédrez | Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft. |
| 000116 (2005) | Eric Mirallié (France) ; Catherine Saï-Maurel ; Alain Faivre-Chauvet ; Nicolas Regenet ; Chien-Hsing Chang ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Philippe Thedrez | Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody. |
| 000043 (2011) | Eliot P Botosoa (France) ; Mike Maillasson ; Marie Mougin-Degraef ; Patricia Remaud-Le Saëc ; Jean-François Gestin ; Yannick Jacques ; Jacques Barbet ; Alain Faivre-Chauvet | Antibody-Hapten Recognition at the Surface of Functionalized Liposomes Studied by SPR: Steric Hindrance of Pegylated Phospholipids in Stealth Liposomes Prepared for Targeted Radionuclide Delivery. |
| 000020 (2012) | Arnaud Briat (France) ; Christiane H F Wenk ; Mitra Ahmadi ; Michael Claron ; Didier Boturyn ; Véronique Josserand ; Pascal Dumy ; Daniel Fagret ; Jean-Luc Coll ; Catherine Ghezzi ; Lucie Sancey ; Jean-Philippe Vuillez | Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging. |
| 000035 (2011) | Faisal Alshoukr (France) ; Aurélie Prignon ; Luc Brans ; Abdelhak Jallane ; Sandra Mendes ; Jean-Noël Talbot ; Dirk Tourwé ; Jacques Barbet ; Anne Gruaz-Guyon | Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors. |
| 000063 (2009) | Faisal Alshoukr (France) ; Cedric Rosant ; Veronique Maes ; Jallane Abdelhak ; Olivier Raguin ; Samuel Burg ; Laure Sarda ; Jacques Barbet ; Dirk Tourwé ; Didier Pelaprat ; Anne Gruaz-Guyon | Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors. |
| 000081 (2008) | Mitra Ahmadi (France) ; Lucie Sancey ; Arnaud Briat ; Laurent Riou ; Didier Boturyn ; Pascal Dumy ; Daniel Fagret ; Catherine Ghezzi ; Jean-Philippe Vuillez | Chemical and biological evaluations of an (111)in-labeled RGD-peptide targeting integrin alpha(V) beta(3) in a preclinical tumor model. |
| 000315 (????) | Marc Hillairet De Boisferon (France) ; Olivier Raguin ; Cynthia Thiercelin ; Monique Dussaillant ; William Rostène ; Jacques Barbet ; André Pélegrin ; Anne Gruaz-Guyon | Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model. |
| This area was generated with Dilib version V0.5.76. |  |